The British Society of Rheumatology (BSR) has outlined its priorities to help improve outcomes for people with rare rheumatic and musculoskeletal conditions.

Following on from the launch of the two-year update report for the government on implementation of the UK Strategy for Rare Diseases, which reveals significant progress in its commitment to facilitate early diagnosis and access to treatment for people with rare diseases, the BRS says that while strides have been made over the two years, more needs to be done in relation to the 20% of rare conditions that non-hereditary. Continue reading →